The Cost-Effectiveness of Fluvastatin in Hungary Following Successful Percutaneous Coronary Intervention

ISSN： 0920-3206

Source： Cardiovascular Drugs and Therapy, Vol.20, Iss.4, 2006-08, pp. : 309-317

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An Economic Evaluation of Fluvastatin used for the Prevention of Cardiac Events Following Successful First Percutaneous Coronary Intervention in the UK

By Scuffham P.A. Chaplin S.

PharmacoEconomics, Vol. 22, Iss. 8, 2004-01 ,pp. : 525-535

Adis International

Access to resources Recommend Favorite

Fluvastatin cost effective following PCI

Inpharma, Vol. 1, Iss. 1491, 2005-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Fluvastatin cost effective following PCI

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 479, 2005-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Use of Prolonged Bivalirudin Infusions Following Percutaneous Coronary Intervention

By Moser Lynette

Cardiovascular Drugs and Therapy, Vol. 25, Iss. 3, 2011-06 ,pp. : 267-276

Springer Publishing Company

Access to resources Recommend Favorite

Cost-effectiveness of ticagrelor in acute coronary syndromes

By Henriksson Martin Janzon Magnus

Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 13, Iss. 1, 2013-02 ,pp. : 9-18

Informa Healthcare

Access to resources Recommend Favorite